Recent Quotes (30 days)

You have no recent quotes
chg | %

Angel Biotechnology Holdings Plc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

ABH 0.0500
price chart
Angel Biotechnology calls in administrators
The company has a subsidiary, Angel Biomedical, which is also in administration. Share-trading in AIM-listed Angel Biotechnology Holdings has ceased. KPMG said the companies had incurred losses, most recently as a result of difficult trading conditions.
Related articles »  
Diary of a Private Investor: I'm holding biotech despite bubble the bubble fears
According to the top holdings in the Biotech Growth Trust are on the following 2015 valuations; Biogen, 24.5x earnings for 38.7 per cent forecast growth, Celgene 23.8x for 96.8 per cent growth, Amgen 16.9x for 30 per cent growth ...
The Daily Startup: SR One Launches Startup as Biotech VCs Move Upstream
Hot biotech startups are attracting increased venture funding, and venture investors are ensuring a slot in the financing of these types of companies by starting the company themselves, Brian Gormley reports for Dow Jones VentureWire.
Aim — 20 years of a few winners and many losers
Had you invested �1,000 in As Seen on Screen Holdings, the name of the online fashion portal when it listed on Aim in 2001, your initial investment would now be worth a stylish �162,130, equivalent to an annualised return of 45 per cent.
Government urged to protect the UK science budget
The UK pharmaceutical, biotechnology, medical technology and diagnostics sectors generate an estimated annual turnover of �56 billion, and employ 183,000 people, even more in supply chains.
Top fund manager to launch 'Aim' investment trust
Mr Woodford's Patient Capital trust, which lists on the main market on April 21, will favour biotech and medical science businesses.
Fitbug Holdings ups the marketing spend as Kiqplan 2 launch approaches
Results from digital health monitoring specialist Fitbug (LON:FITB) tell a story of a company that is investing heavily to take advantage of a fast-growing market.
IGas in the spotlight after busy summer for UK frackers
IGas Energy (LON:IGAS), a small London listed company with a large exposure to onshore UK shale reserves, has had a busy time of it recently.
Sirius expected to get key permit decision shortly, says Shore
UK potash mine developer Sirius Minerals (LON:SXX) received a repeated 'buy' rating from Shore Capital today, which says it is expecting the firm to get a key planning decision shortly.
ARM Holdings lays to rest royalty revenue fears
The ARM Holdings (LON:ARM) growth story continues with the chip designer laying to rest fears about slowing growth in the semiconductor market.